Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets.

PARs (protease-activated receptors) 1 and 4 belong to the family of G-protein-coupled receptors which induce both G(α12/13) and G(αq) signalling. By applying the specific PAR1- and PAR4-activating hexapeptides, SFLLRN and AYPGKF respectively, we found that aggregation of isolated human platelets mediated via PAR1, but not via PAR4, is abolished upon homologous receptor activation in a concentration- and time-dependent fashion. This effect was not due to receptor internalization, but to a decrease in Ca²⁺ mobilization, PKC (protein kinase C) signalling and α-granule secretion, as well as to a complete lack of dense granule secretion. Interestingly, subthreshold PAR4 activation rapidly abrogated PAR1 signalling desensitization by differentially reconstituting these affected signalling events and functional responses, which was sufficient to re-establish aggregation. The lack of ADP release and P2Y₁₂ receptor-induced G(αi) signalling accounted for the loss of the aggregation response, as mimicking G(αi/z) signalling with 2-MeS-ADP (2-methylthioadenosine-5'-O-diphosphate) or epinephrine (adrenaline) could substitute for intermediate PAR4 activation. Finally, we found that the re-sensitization of PAR1 signalling-induced aggregation via PAR4 relied on PKC-mediated release of both ADP from dense granules and fibrinogen from α-granules. The present study elucidates further differences in human platelet PAR signalling regulation and provides evidence for a cross-talk in which PAR4 signalling counteracts mechanisms involved in PAR1 signalling down-regulation.

[1]  P. Gunnarsson,et al.  α1-acid glycoprotein (AGP)-induced platelet shape change involves the Rho/Rho kinase signalling pathway , 2009, Thrombosis and Haemostasis.

[2]  E. Scott,et al.  Loss of pleckstrin defines a novel pathway for PKC-mediated exocytosis. , 2009, Blood.

[3]  P. Verkade,et al.  PKCalpha regulates platelet granule secretion and thrombus formation in mice. , 2009, Journal of Clinical Investigation.

[4]  G. Baldanzi,et al.  The Gi-coupled P2Y12 Receptor Regulates Diacylglycerol-mediated Signaling in Human Platelets* , 2008, Journal of Biological Chemistry.

[5]  H. Hamm,et al.  PAR1, but Not PAR4, Activates Human Platelets through a Gi/o/Phosphoinositide-3 Kinase Signaling Axis , 2007, Molecular Pharmacology.

[6]  T. Lindahl,et al.  Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development , 2007, Thrombosis and Haemostasis.

[7]  C. Derian,et al.  Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis , 2006, Circulation.

[8]  T. Kawakami,et al.  A role for PKCθ in outside‐in αIIbβ3 signaling , 2006 .

[9]  T. Kawakami,et al.  Regulation of Outside-in Signaling in Platelets by Integrin-associated Protein Kinase Cβ* , 2005, Journal of Biological Chemistry.

[10]  J. Trejo Protease-Activated Receptors: New Concepts in Regulation of G Protein-Coupled Receptor Signaling and Trafficking , 2003, Journal of Pharmacology and Experimental Therapeutics.

[11]  I. Bièche,et al.  An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. , 2003, Blood.

[12]  L. Brass,et al.  Signaling through Gi Family Members in Platelets , 2002, The Journal of Biological Chemistry.

[13]  B. Nieswandt,et al.  Costimulation of Gi- and G12/G13-mediated Signaling Pathways Induces Integrin αIIbβ3 Activation in Platelets* , 2002, The Journal of Biological Chemistry.

[14]  C. Foster,et al.  Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. , 2002, Blood.

[15]  C. Gachet Identification, Characterization, and Inhibition of the Platelet ADP Receptors , 2001, International journal of hematology.

[16]  C. Foster,et al.  Unique Pathway of Thrombin-induced Platelet Aggregation Mediated by Glycoprotein Ib* , 2001, The Journal of Biological Chemistry.

[17]  F. Rendu,et al.  The platelet release reaction: granules' constituents, secretion and functions , 2001, Platelets.

[18]  M. LeMasurier,et al.  Substrate-Assisted Catalysis of the PAR1 Thrombin Receptor , 2000, The Journal of Biological Chemistry.

[19]  S. Coughlin,et al.  Protease-activated Receptors 1 and 4 Are Shut Off with Distinct Kinetics after Activation by Thrombin* , 2000, The Journal of Biological Chemistry.

[20]  A. Kuliopulos,et al.  Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. , 2000, Biochemistry.

[21]  S. Kunapuli,et al.  Platelet Shape Change Is Mediated by both Calcium-dependent and -independent Signaling Pathways , 1999, The Journal of Biological Chemistry.

[22]  M. Aepfelbacher,et al.  Dichotomous Regulation of Myosin Phosphorylation and Shape Change by Rho-Kinase and Calcium in Intact Human Platelets , 1999 .

[23]  S. Coughlin,et al.  Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. , 1999, The Journal of clinical investigation.

[24]  G. FitzGerald,et al.  Phosphorylation of the Thromboxane Receptor α, the Predominant Isoform Expressed in Human Platelets* , 1999, The Journal of Biological Chemistry.

[25]  A. Malik,et al.  Protein kinase Cβ regulates heterologous desensitization of thrombin receptor (PAR-1) in endothelial cells. , 1998, American journal of physiology. Cell physiology.

[26]  Stefan Offermanns,et al.  Defective platelet activation in Gαq-deficient mice , 1997, Nature.

[27]  J. Hoxie,et al.  Thrombin Receptors on Human Platelets , 1997, The Journal of Biological Chemistry.

[28]  B. Nürnberg,et al.  The human platelet ADP receptor activates Gi2 proteins. , 1995, The Biochemical journal.

[29]  G. Schultz,et al.  G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Chen,et al.  Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. , 1994, The Journal of biological chemistry.

[31]  J. Kutok,et al.  Immunologic analysis of the cloned platelet thrombin receptor activation mechanism: evidence supporting receptor cleavage, release of the N-terminal peptide, and insertion of the tethered ligand into a protected environment. , 1993, Blood.

[32]  V. Steen,et al.  The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro. , 1993, Thrombosis and haemostasis.

[33]  D. Loskutoff,et al.  Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. , 1984, The Journal of clinical investigation.

[34]  T. Lindahl,et al.  Platelet PAR1 receptor density--correlation to platelet activation response and changes in exposure after platelet activation. , 2008, Thrombosis research.

[35]  B. Nieswandt,et al.  Activation of Platelet Function Through G Protein–Coupled Receptors , 2006, Circulation research.

[36]  R. Lefkowitz,et al.  Signalling: Seven-transmembrane receptors , 2002, Nature Reviews Molecular Cell Biology.